Patent details

EP3067363 Title: A PROCESS FOR CRYSTALLIZATION OF CYCLOSPORIN A FORM 2

Basic Information

Publication number:
EP3067363
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161560925
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A PROCESS FOR CRYSTALLIZATION OF CYCLOSPORIN A FORM 2
French Title of Invention:
PROCÉDÉ DE CRYSTALLISATION DE LA CYCLOSPORINE A EN FORME 2
German Title of Invention:
VERFAHREN ZUR KRISTALLISIERUNG CYCLOSPORIN A FORM 2
SPC Number:

Dates

Filing date:
14/11/2012
Grant date:
17/01/2018
EP Publication Date:
14/09/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/01/2018
EP B1 Publication Date:
17/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/11/2018
Expiration date:
14/11/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/01/2018
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
Wu, Ke
Address:
United States (US)

2

Name:
Smith, Scott W.
Address:
United States (US)

Priority

Priority Number:
201161559830 P
Priority Date:
15/11/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 38/13; C07K 1/30; C07K 7/64;

Publication

European Patent Bulletin

Issue number:
201803
Publication date:
17/01/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1